OpenAI has moved GPT-Rosalind out of research preview, opening its biology-focused reasoning model to qualifying organizations worldwide through the API, Codex, and ChatGPT Enterprise, while extending Codex with a dedicated Life Sciences plugin covering genomics, protein structure, quality-control reporting, and lab notebooks. The rollout marks the model's shift from a narrow, US-only pilot into a broader but still gated release, and it arrives alongside a growing toolkit meant to let scientists run multi-step biology research directly inside OpenAI's coding agent.
Continue reading
The rest of this article is for AI News Blitz readers. Choose an option below to keep reading.
Already purchased? Sign in✓ Signed in — this article isn’t included in your current plan.
Unlocking the full article...
Contact us
Questions, corrections, or ideas? Send us a message here. We aim to reply by email within 24 hours.
Thank you. Your message has been sent. We aim to reply by email within 24 hours.Please enter your email address and a message.We could not send your message. Please try again in a little while.